Pharma Deals Review, Vol 2006, No 70 (2006)

Font Size:  Small  Medium  Large

Neuromed Pharmaceuticals and Merck Collaborate for Novel Pain Drugs

Business Review Editor

Abstract


Neuromed and Merck & Co. entered into a research collaboration and worldwide licensing agreement to develop and commercialize novel compounds to treat chronic pain including the Neuromed’s Phase II compound, NMED-160.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.